PureTech Health PLC
OTC:PTCHF
Balance Sheet
Balance Sheet Decomposition
PureTech Health PLC
PureTech Health PLC
Balance Sheet
PureTech Health PLC
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
11
|
7
|
62
|
135
|
63
|
73
|
117
|
132
|
404
|
466
|
150
|
191
|
281
|
|
| Cash Equivalents |
11
|
7
|
62
|
135
|
63
|
73
|
117
|
132
|
404
|
466
|
150
|
191
|
281
|
|
| Short-Term Investments |
1
|
2
|
1
|
180
|
219
|
117
|
136
|
32
|
2
|
2
|
202
|
138
|
100
|
|
| Total Receivables |
1
|
3
|
2
|
1
|
0
|
2
|
1
|
2
|
3
|
23
|
22
|
14
|
2
|
|
| Accounts Receivables |
1
|
3
|
2
|
1
|
0
|
2
|
1
|
2
|
3
|
3
|
12
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
10
|
12
|
0
|
|
| Other Current Assets |
1
|
1
|
2
|
3
|
6
|
7
|
5
|
2
|
5
|
11
|
12
|
4
|
4
|
|
| Total Current Assets |
14
|
12
|
67
|
318
|
288
|
198
|
260
|
169
|
414
|
502
|
386
|
347
|
386
|
|
| PP&E Net |
1
|
1
|
1
|
5
|
7
|
7
|
8
|
44
|
43
|
44
|
37
|
19
|
15
|
|
| PP&E Gross |
1
|
1
|
1
|
5
|
7
|
7
|
8
|
44
|
43
|
44
|
37
|
19
|
15
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
2
|
4
|
6
|
7
|
11
|
14
|
20
|
13
|
13
|
|
| Intangible Assets |
3
|
3
|
3
|
4
|
4
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
5
|
6
|
|
| Long-Term Investments |
1
|
0
|
0
|
0
|
0
|
131
|
170
|
726
|
530
|
397
|
278
|
326
|
200
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
|
| Total Assets |
19
N/A
|
17
-13%
|
71
+323%
|
327
+360%
|
299
-9%
|
340
+14%
|
442
+30%
|
941
+113%
|
990
+5%
|
946
-4%
|
703
-26%
|
694
-1%
|
603
-13%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
2
|
2
|
3
|
5
|
11
|
9
|
11
|
27
|
15
|
6
|
|
| Accrued Liabilities |
2
|
1
|
3
|
5
|
9
|
13
|
11
|
9
|
9
|
22
|
26
|
29
|
21
|
|
| Short-Term Debt |
2
|
4
|
7
|
5
|
7
|
8
|
12
|
2
|
27
|
4
|
2
|
4
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
5
|
10
|
3
|
4
|
|
| Other Current Liabilities |
17
|
17
|
82
|
148
|
186
|
250
|
238
|
115
|
133
|
184
|
32
|
0
|
8
|
|
| Total Current Liabilities |
21
|
23
|
94
|
161
|
204
|
274
|
266
|
139
|
181
|
226
|
97
|
51
|
41
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
35
|
47
|
43
|
34
|
18
|
15
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
4
|
6
|
115
|
109
|
90
|
20
|
52
|
0
|
|
| Minority Interest |
6
|
7
|
45
|
62
|
85
|
150
|
109
|
18
|
16
|
9
|
5
|
6
|
7
|
|
| Other Liabilities |
1
|
2
|
1
|
2
|
2
|
2
|
3
|
1
|
0
|
3
|
4
|
114
|
139
|
|
| Total Liabilities |
16
N/A
|
18
+10%
|
49
+177%
|
101
+105%
|
121
+20%
|
130
+7%
|
166
+28%
|
273
+64%
|
320
+17%
|
353
+10%
|
160
-54%
|
230
+43%
|
188
-18%
|
|
| Equity | ||||||||||||||
| Common Stock |
1
|
1
|
2
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
2
|
2
|
20
|
40
|
8
|
23
|
8
|
375
|
375
|
298
|
274
|
213
|
166
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
182
|
182
|
182
|
278
|
288
|
289
|
289
|
290
|
290
|
290
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
45
|
47
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Total Equity |
3
N/A
|
1
N/A
|
22
N/A
|
226
+928%
|
178
-21%
|
210
+18%
|
276
+31%
|
668
+142%
|
670
+0%
|
594
-11%
|
542
-9%
|
464
-14%
|
415
-11%
|
|
| Total Liabilities & Equity |
19
N/A
|
17
-13%
|
71
+323%
|
327
+360%
|
299
-9%
|
340
+14%
|
442
+30%
|
941
+113%
|
990
+5%
|
946
-4%
|
703
-26%
|
694
-1%
|
603
-13%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
227
|
227
|
227
|
226
|
233
|
237
|
283
|
285
|
286
|
288
|
289
|
272
|
239
|
|